These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6576383)

  • 21. Effects of Fluosol-DA and oxygen breathing on adriamycin antitumor activity and cardiac toxicity in mice.
    Teicher BA; Holden SA; Crawford JM
    Cancer; 1988 Jun; 61(11):2196-201. PubMed ID: 3365649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fundamental and clinical studies on intracadaveric organ perfusion with Fluosol-DA.
    Honda K
    Prog Clin Biol Res; 1983; 122():327-30. PubMed ID: 6348786
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased radiosensitivity of tumors by perfluorochemicals and carbogen.
    Song CW; Zhang WL; Pence DM; Lee I; Levitt SH
    Int J Radiat Oncol Biol Phys; 1985 Oct; 11(10):1833-6. PubMed ID: 3930442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Fluosol-DA hemodilution on the kinetics of hepatically eliminated drugs.
    Shrewsbury RP
    Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):375-96. PubMed ID: 3575876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Fluosol-DA during open-heart surgery.
    Engelman RM; Dobbs WA; Rousou JH; Anisimowicz L
    Prog Clin Biol Res; 1983; 122():273-82. PubMed ID: 6878370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of artificial blood substitute (fluosol-DA 20%) in patients of cerebral ischemia].
    Oda Y; Murata T; Uchida Y; Mori K; Nagasawa S; Naruo Y; Asato R; Handa H
    No Shinkei Geka; 1982 Jun; 10(6):637-44. PubMed ID: 7121730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorocarbons and the microcirculation.
    Faithfull NS; Fennema M; Van Alphen WA; Smith AR; Erdmann W; Essed CE; Kok A; Lapin R
    Acta Anaesthesiol Belg; 1984; 35 Suppl():69-78. PubMed ID: 6516761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal and fetal effects of exchange transfusion with a red blood cell substitute.
    Cefalo RC; Seeds JW; Proctor HJ; Baker VV
    Am J Obstet Gynecol; 1984 Apr; 148(7):859-67. PubMed ID: 6711627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of hemodilution with fluorocarbon or dextran on regional myocardial flow and function during acute coronary stenosis in the pig.
    Biro GP; White FC; Guth BD; Breisch EA; Bloor CM
    Am J Cardiovasc Pathol; 1987 Jan; 1(1):99-114. PubMed ID: 2458118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of oxygen-carrying resuscitation fluids on the pharmacokinetics of antipyrine, diazepam, penicillin, and sulfamethazine in rats.
    Kemner JM; Snodgrass WR; Worley SE; Hodges GR; Melethil S; Hignite CE; Tschanz C
    Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):381-400. PubMed ID: 6515128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Perfluorochemicals (FDA-20%, fluosol), available as cardioplegic solution].
    Nomoto S; Inoue K; Horiuchi M; Yokokawa H; Takaba T; Ishii J
    Kokyu To Junkan; 1985 Nov; 33(11):1355-60. PubMed ID: 4095390
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of Fluosol-DA/O2 on the antitumor activity and pulmonary toxicity of bleomycin.
    Teicher BA; Lazo JS; Merrill WW; Filderman AE; Rose CM
    Cancer Chemother Pharmacol; 1986; 18(3):213-8. PubMed ID: 2433068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluosol DA-20% in treatment of severe anemia: ongoing studies in 52 patients.
    Spence RK; McCoy S; Costabile J; Norcross ED; Pello M; Alexander J; Atabek U; Wisdom C; Camishion R
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1069. PubMed ID: 1391428
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
    Suyama T; Yokoyama K; Naito R
    Prog Clin Biol Res; 1981; 55():609-28. PubMed ID: 7027272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial results of a clinical trial of Fluosol-DA 20 percent in acute cerebral ischemia.
    Swann KW; Ropper AH; Zervas NT
    Prog Clin Biol Res; 1983; 122():399-404. PubMed ID: 6348787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of fetal exchange transfusion with a red blood cell substitute.
    Ambrose A; Cefalo RC; Bowes WA
    Am J Obstet Gynecol; 1986 Mar; 154(3):667-74. PubMed ID: 3082209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of perfluorochemicals on BCNU chemotherapy: preliminary study in a rat brain tumor model.
    Kokunai T; Kuwamura K
    Surg Neurol; 1982 Oct; 18(4):258-61. PubMed ID: 7179085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Red cell substitutes: hemoglobin solution or fluorocarbon?
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Rice CL; Moss GS
    J Trauma; 1982 Sep; 22(9):736-40. PubMed ID: 7120525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA) Summary of 186 cases.
    Mitsuno T; Ohyanagi H; Naito R
    Ann Surg; 1982 Jan; 195(1):60-9. PubMed ID: 7034658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Artificial blood. Experimental studies on fluorocarbons as chemical blood substitutes].
    Motta G; Grunert A; Herrmann M; Ratto GB; Spinelli E; Lunghi C; Tomellini M; Bisio E; Hirlinger WK; Mayer M
    Minerva Med; 1983 Jan; 74(1-2):1-18. PubMed ID: 6337348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.